Takeda Pharmaceutical Company
Tracked across 7 events · 47 articles · First seen Feb 19, 2026 · Last active Jun 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Impact: Takeda Pharmaceutical Company terminated its collaboration agreement with Denali Therapeutics for DNL593 due to strategic considerations, not related to efficacy or safety data.
Apr 03, 2026 · 7 articles
Tech
Innovent Biologics announced updated long-term follow-up data from its Phase 1 PoC clinical study of IBI363 (PD-1/IL-2 bispecific fusion protein) in advanced immunotherapy-resistant non-small cell lung cancer (NSCLC) at the 2026 American Society of Clinical…
Impact: Takeda Pharmaceutical Company is co-developing IBI363 with Innovent Biologics and will exclusively commercialize it globally outside the U.S. and greater China. The positive clinical results for IBI363 strengthen Takeda's oncology portfolio and future revenue potential.
May 21, 2026 · 9 articles
Business
AnBogen Therapeutics announced that its President and CEO, Dinesh V. Patel, Ph.D., will participate in two investment bank conferences in June 2026: the 2026 Jefferies Global Healthcare Conference and the Goldman Sachs 47th Annual Global…
Impact: Takeda Pharmaceutical Company is the licensee for rusfertide, another peptide discovered by AnBogen Therapeutics.
May 28, 2026 · 6 articles
Regulatory
Brazil has temporarily suspended the use of its single-dose dengue vaccine after two suspicious deaths and 42 severe reactions were reported among the more than half a million people vaccinated. Health Minister Alexandre Padilha stated…
Impact: Takeda is the Japanese laboratory that produces another dengue vaccine, which continues to be used without problems in Brazil, potentially seeing increased demand due to the suspension of the local vaccine.
Jun 08, 2026 · 7 articles
Tech
Impact: Takeda Pharmaceutical Company Limited is a funding partner for the project, supporting the research into Alzheimer s disease biomarkers.
Feb 19, 2026 · 6 articles
Tech
Impact: Takeda Pharmaceutical Company is a sponsor of World Hemophilia Day 2026, supporting the World Federation of Hemophilia's efforts.
Apr 17, 2026 · 6 articles
Business
Kymera Therapeutics, a clinical-stage biopharmaceutical company, announced the appointment of Penny Carlson as Senior Vice President, Development Operations. Ms. Carlson brings over two decades of biopharmaceutical leadership experience and will oversee Kymera's global clinical development…
Impact: Penny Carlson previously served as Vice President and Head of Global Clinical Development Operations at Takeda Pharmaceutical Company, indicating her extensive experience in the biopharmaceutical industry.
Jun 08, 2026 · 6 articles
70
Innovent Biologics co-developed IBI363 Takeda Pharmaceutical CompanyIBI363 Shows Survival...
NEWSDESK
Track Takeda Pharmaceutical Company live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard